Web1990 Sales surpass $2,000,000,000 for the first time.. 1991 BD launched the first auto-disable immunization device.. 1991 Pen needle is introduced.. 1991 BD opens a central distribution center in Temsee, Belgium to ship medical products across Europe, the middle east, and Africa.. 1992 BD introduced the BD Vacutainer® Safety-Lok™ Blood Collection … WebThe RPA-T8 antibody is specific for the 32-34 kDa alpha chain of human CD8, known as CD8a or CD8 alpha. CD8a can form a homodimer (CD8 alpha-alpha), but is more commonly expressed as a heterodimer with a second chain known as CD8b or CD8 beta. CD8 acts as a co-receptor for antigen recognition and subsequent T cell activation that is initiated ...
BV421 Mouse Anti-Human CD8 - BD Biosciences
WebThe antibody was conjugated to BD Horizon™ BV421 which is part of the BD Horizon Brilliant™ Violet family of dyes. With an Ex Max of 407-nm and Em Max at 421-nm, BD … WebDescription The RPA-T8 monoclonal antibody specifically binds to CD8 alpha (CD8α) . CD8α is a type I transmembrane glycoprotein and a member of the immunoglobulin superfamily. CD8α is expressed by the majority of thymocytes, by subpopulations of αβ T cells and γδ T cells and by some NK cells. cleveland livability
Brilliant Violet 421™ anti-human CD8a Antibody - BioLegend
WebClone SK1 (also known as Leu-2a; Leu2a) Multiparameter Flow cytometric analysis using BD OptiBuild™ BV421 Mouse Anti-Human CD8 antibody (Cat. No. 740093) on human … WebThe RPA-T8 and HIT8a monoclonal antibodies are not cross-blocking. The antibody was conjugated to BD Horizon™ BV650 which is part of the BD Horizon™ Brilliant Violet™ family of dyes. This dye is a tandem fluorochrome of BD Horizon™ BV421 with an Ex Max of 405-nm and an acceptor dye with an Em Max at 650-nm. Web(562428) BD Horizon™ BV421 Mouse Anti-Human CD8 - BD Biosciences - CiteAb 27 citations – A Brilliant Violet 421-conjugated mouse monoclonal antibody, raised against T-cell surface glycoprotein CD8 alpha chain (Human), supplied by BD Biosciences. cleveland live